Contents
Current Medicinal Chemistry - Central Nervous System Agents, Volume 3 - Number 1
Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse
, 3(1): 1 - 26Sergi Ferre, Francisco Ciruela, Amina S. Woods, Meritxell Canals, Javier Burgueno, Daniel Marcellino, Marzena Karcz-Kubicha, Bruce T. Hope, Marisela Morales, Patrizia Popoli, Steven R. Goldberg, Kjell Fuxe, Carme Lluis, Rafael Franco and Luigi Agnati
DOI: 10.2174/1568015033357779
Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: Past and Future Roles of 5-HT4 Receptor Agonists
, 3(1): 27 - 36Henri Mattes and Hans-Juergen Pfannkuche
DOI: 10.2174/1568015033357724
Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: 5-HT4 Receptor Antagonists
, 3(1): 37 - 42Henri Mattes and Hans-Juergen Pfannkuche
DOI: 10.2174/1568015033357742
The Therapeutic Potential of Amphetamines in Post-stroke Recovery
, 3(1): 49 - 55Anwar Khokar, Jawad F. Kirmani, Andrew R. Xavier and Adnan I. Qureshi
DOI: 10.2174/1568015033357751
Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling
, 3(1): 57 - 65Jeffrey K. Yao and Ravinder D. Reddy
DOI: 10.2174/1568015033357797
Webmaster Contact: info@benthamscience.org